<DOC>
	<DOCNO>NCT00095368</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy APC-111 775 mg MP tablet daily dose 7 day treat patient strep throat . The evaluation look confirm APC-111 eliminate bacterial infection ( Streptococcus pyogenes ) .</brief_summary>
	<brief_title>APC-111 Once Day ( QD ) 7 Days v . Penicillin Taken Four Times Day ( QID ) 10 Days Patients With Strep Throat</brief_title>
	<detailed_description />
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Tonsillitis</mesh_term>
	<mesh_term>Penicillins</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Give informed consent , assent patient authorization Age 12 A clinical diagnosis acute pharyngitis tonsillitis A positive rapid Strep test Can swallow oral study dosage form Females must negative urine pregnancy test use acceptable birth control sexually active Chronic recurrent odynophagia Need hospitalization IV antimicrobial therapy Pharyngitis know suspect due pathogen resistant betalactam antimicrobial Known carrier S. pyogenes Allergies penicillin betalactam antibiotic Any serious illness concomitant condition investigator judge preclude inclusion study Seizure disorder Pregnant nursing Expectation additional systemic antibacterial would require another condition Current drug alcohol abuse Any experimental drug device within last 30 day Prior systemic antibiotic therapy within last 30 day Hospitalization within last month include antibacterial therapy The presence clinically significant hematologic condition , etc Probenecid treatment</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2005</verification_date>
	<keyword>Pharyngitis</keyword>
	<keyword>Tonsillitis</keyword>
</DOC>